Global Next Generation Antibody Therapeutics Market Size, Status and Forecast 2019-2025

SKU ID : QYR- 13679811

Publishing Date : 10-Jul-2019

No. of pages : 90

PRICE
3900
7800

  • The ADCs segment held the largest market share in the historical period and is projected to hold a market share of over 50% by 2025. The Fc engineered antibodies segmented is projected to witness the fastest growth during the forecast period.
    Geographically, North America dominates the next-generation antibody therapeutics market due to growing R&D activities and technological advancements in antibody therapeutics in the region. In addition, the increasing prevalence of chronic diseases and growing healthcare expenditure are fueling the growth of the next-generation antibody therapeutics market in North America. Moreover, the increasing healthcare expenditure is driving the market for next-generation antibody therapeutics in North America.
    In 2018, the global Next Generation Antibody Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

    This report focuses on the global Next Generation Antibody Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Antibody Therapeutics development in United States, Europe and China.

    The key players covered in this study
    Pfizer
    Roche
    Bristol-Myers Squibb
    Amgen
    AstraZeneca
    Bayer
    Takeda Pharmaceuticals
    Biogen
    Seattle Genetics
    ImmunoGen
    Kyowa Hakko Kirin
    Xencor
    Dyax Corp

    Market segment by Type, the product can be split into
    Antibody Drug Conjugates (ADCs)
    Bispecific Antibodies (BsAbs)
    Fc Engineered Antibodies
    Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
    Biosimilar Antibody (Ab) Products

    Market segment by Application, split into
    Hospitals
    Clinics
    Others

    Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Next Generation Antibody Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the Next Generation Antibody Therapeutics development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Next Generation Antibody Therapeutics are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports